ABBOTT INDIA
Back to Income Statement
|
ABBOTT INDIA Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹6,409 Cr | ₹5,849 Cr | ₹5,349 Cr | ₹4,913 Cr | ₹4,310 Cr |
What is the latest Revenue of ABBOTT INDIA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹6,409 Cr |
| Mar2025 | ₹5,849 Cr |
| Mar2024 | ₹5,349 Cr |
| Mar2023 | ₹4,913 Cr |
| Mar2022 | ₹4,310 Cr |
How is Revenue of ABBOTT INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,409 Cr | 9.58 | |
| Mar2025 | ₹5,849 Cr | 9.35 | |
| Mar2024 | ₹5,349 Cr | 8.86 | |
| Mar2023 | ₹4,913 Cr | 14.00 | |
| Mar2022 | ₹4,310 Cr | - | |
Compare Revenue of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹57,053.0 Cr | 4% | 2% | -12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 4% |
2% |
-12% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses